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Abstract 
Autoimmune pancreatitis (AIP) can be difficult to distinguish from pancreatic cancer. 
We report a case of histopathologically proven AIP mimicking neuroendocrine tumor 
(NET) or pancreatic cancer in a 53-year-old man. He was referred to our hospital for 
further evaluation of a pancreatic mass detected on ultrasonography at a medical 
check-up. Abdominal ultrasonography showed a 15-mm hypoechoic mass located in 
the pancreatic body. Computed tomography revealed a tumor without any contrast 
enhancement, and magnetic resonance imaging demonstrated the mass to be hyperintense 
on diffusion-weighted image. Endoscopic retrograde cholangiopancreatography revealed 
slight dilatation of a branch of the pancreatic duct without stricture of the main pancreatic 
duct. The common bile duct seemed intact. Under suspicion of a non-functioning NET or 
malignant neoplasm, laparotomy was performed. At laparotomy, an elastic firm and 
well-circumscribed mass was found suggestive of a non-functioning NET, thus enucleation 
was performed. Histopathologically, the lesion corresponded to AIP. 
 
Introduction 
Autoimmune pancreatitis (AIP) is a type of chronic pancreatitis characterized by an 
autoimmune inflammatory process in which prominent lymphocyte infiltration with 
associated fibrosis of the pancreas causes organ dysfunction. AIP is a rare disease.  
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Although there has been an increase in the number of reports of AIP in recent years, 
the overall number of patients is still relatively small. Three series have reported the 
prevalence of AIP as between 5 and 6% of all patients with chronic pancreatitis [1]. 
Clinically, AIP is characterized by a preponderance of elderly males, jaundice as a 
frequent initial symptom, an association with various sclerosing extrapancreatic 
lesions, such as sclerosing cholangitis, sclerosing sialadenitis, and retroperitoneal 
fibrosis, showing similar histological findings to the pancreas with elevated serum 
IgG or IgG4 levels. Therefore, AIP can be considered to be a pancreatic lesion of 
IgG4-related systemic disease, and its extrapancreatic lesions are clinical 
manifestations of organs involved in this systemic disease. AIP sometimes forms a 
pancreatic mass lesion, which can often be difficult to distinguish from pancreatic 
cancer, and this diagnostic uncertainty can lead to pancreatic resection for benign 
disease. We report a case of AIP with the formation of a mass mimicking 
neuroendocrine tumor (NET) or pancreatic cancer without any specific findings and 
review the relevant literature. 
Case Report 
In December 2007, a 53-year-old man was referred to our hospital for further evaluation of a 
pancreatic mass detected on ultrasonography at a medical check-up. He denied abdominal pain, 
nausea, vomiting, or weight loss. Vital signs were stable and the findings of physical examination were 
unremarkable. He had no history of alcohol consumption, smoking, or family history of pancreatic or 
any other gastrointestinal disease. The results of the laboratory test were almost within normal limits 
except for slightly elevated gastrin. Levels of pancreatic hormones such as insulin and glucagon were 
within the normal ranges. IgG serum level was normal and antinuclear antibody test was negative 
(table 1). Abdominal ultrasonography showed a 15-mm hypoechoic mass located in the pancreatic 
body without dilatation of the main pancreatic duct (fig. 1a). Computed tomography revealed a tumor 
in the pancreatic body without any contrast enhancement (fig. 1b). Magnetic resonance imaging 
demonstrated the mass to be hyperintense on diffusion-weighted image (fig. 1c). Endoscopic 
retrograde cholangiopancreatography revealed slight dilatation of a branch of the pancreatic duct in 
the pancreatic body without stricture of the main pancreatic duct (fig. 1d). The common bile duct 
seemed intact, and cytology of the pancreatic juice was class II. Endoscopic ultrasonography revealed 
a partially encapsulated hypoechoic mass in the body of the pancreas abutting the splenic vein. On 
the basis of these findings, a non-functioning NET or malignant neoplasm were suspected, and 
laparotomy was performed. At laparotomy, an elastic firm mass well circumscribed by a thin wall 
suggestive of a NET was found at the pancreatic body. Therefore enucleation was performed (fig. 2a). 
The tumor could be easily dissected. Intraoperative frozen section revealed no evidence of 
malignancy, thus further excision was not attempted. Histologically, the tumor was partially 
indiscrete and showed extensive fibrosis, and demonstrated infiltration of lymphocytes, plasma cells, 
and eosinophils with lymphoid follicles around the pancreatic duct and pancreatic parenchyma, and 
obliterative venulitis, which are typical features of AIP (fig. 2b). Subsequently, immunohistological 
examination demonstrated that the pancreatic duct was surrounded by abundant IgG4-positive 
plasma cells (fig. 2c). On the basis of these findings, the tumor was diagnosed as AIP. Postoperatively, 
the level of serum IgG increased but then decreased to normal limits without any treatment, and the 
patient is currently doing well.  
Discussion 
AIP is a particular type of pancreatitis that is thought to have an autoimmune 
etiology. Since Yoshida et al. proposed AIP as a disease entity in 1995, many cases of 
AIP have been reported in Japan, and AIP has received increasing awareness and better 
understanding worldwide [2]. The diagnosis of focal forms can be difficult as AIP may  
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mimic pancreatic adenocarcinoma [3–5]. Therefore, there have been several cases of 
AIP in whom resection was performed because of a high suspicion of pancreatic cancer 
[6, 7]. In the past decade, many different diagnostic criteria for AIP have been proposed 
from Asia, Europe and North America [8–11]. In 2002, diagnostic criteria for AIP were 
proposed first in the world by the Japan Pancreas Society and revised in 2006 [8, 9]. 
These criteria are based on the minimum consensus of AIP and aim to avoid 
misdiagnosing pancreatic cancer as much as possible, but not to screen for AIP. These 
criteria consist of the following radiological, serological, and histopathological items: 
(1) radiological imaging showing narrowing of the main pancreatic duct and 
enlargement of the pancreas, which are characteristic of the disease; (2) laboratory 
data showing abnormally elevated levels of serum gamma globulin, IgG or IgG4, or the 
presence of autoantibodies; (3) histopathological examination of the pancreas 
demonstrating marked fibrosis and prominent infiltration of lymphocytes and plasma 
cells, which is called lymphoplasmacytic sclerosing pancreatitis (LPSP). For a diagnosis 
of AIP, criterion 1 must be present, together with criterion 2 and/or criterion 3. 
However, it is necessary to exclude malignant diseases such as pancreatic or biliary 
cancer. In 2006, two new sets of diagnostic criteria for AIP were proposed, in Korea and 
the United States (Mayo Clinic), respectively [10, 11]. These criteria included ‘response 
to steroid’ as one of the diagnostic items. When response to steroid therapy is added to 
the criteria, the diagnostic sensitivity is increased. However, in the diagnostic criteria in 
Japan, ‘response to steroid’ is excluded. It is possible that the ready use of steroids by 
general physicians inexperienced in pancreatic disease will delay the diagnosis of 
pancreatic cancer, which may lead to cancer progression in some cases [12]. We agree 
that a trial of steroid therapy should be avoided in the absence of the typical features of 
AIP, such as in our case, for whom non-functioning NET or pancreatic cancer were 
suspected without considering AIP in the differential diagnosis, and laparotomy was 
performed because no specific findings in the criteria of AIP had been seen. Endoscopic 
ultrasonography-guided fine-needle aspiration is frequently used worldwide to rule out 
pancreatic cancer, however its yield for cancer is not perfect, and negative biopsy does 
not rule out cancer [13, 14].  
In 2011, the international consensus diagnostic criteria for AIP were proposed. AIP 
was classified into two types [15]. In one form the histological description is called 
LPSP or AIP without granulocyte epithelial lesions. The other form is idiopathic 
duct-centric pancreatitis (IDCP) or AIP with granulocyte epithelial lesions. Clinically, 
LPSP seems to be the pancreatic manifestation of an IgG4-related systemic disease 
characterized by elevated serum IgG4 levels and extrapancreatic lesions such as 
sclerosing cholangitis, sclerosing sialadenitis, and retroperitoneal fibrosis associated 
with infiltration with abundant IgG4-positive plasma cells. In contrast, IDCP usually has 
no or very few IgG4-positive plasma cells, although this can vary. IDCP does not seem to 
be a systemic disease; rather, it seems to be a pancreas-specific disorder. Since IDCP 
patients are seronegative and lack other organ involvement, a definitive diagnosis 
requires pancreatic histology.  
The present case seems to be LPSP because of histological features of abundant 
IgG4-positive cells infiltrating the pancreatic duct. The patient therefore is followed up 
as an outpatient, with special attention for the appearance of extrapancreatic lesions. 
Although pancreatic tumor in the present case was incidentally detected during 
medical check-up, he was asymptomatic, seronegative and revealing atypical features  
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on imaging, which seems to be a rare presentation of AIP. Clinically, this type of AIP is 
difficult to diagnose or to differentiate from pancreatic cancer.  
In conclusion, we report a rare case of histopathologically proven AIP in whom the 
lesion was small and no characteristic findings were obtained by imaging or blood 
tests.  
Disclosure Statement 
The authors have no conflict of interest. 
 
 
 
Table 1. Laboratory data on admission 
        Total bilirubin  1.6 mg/dl 
Direct bilirubin  0.4 mg/dl 
Alkaline phosphatase  287 IU/l 
Gamma-glutamyl transpeptidase  36 IU/l 
Amylase  91 IU/l 
Lipase  24 IU/l 
Trypsin  410 IU/l 
Elastase-1  160 IU/l 
CA19-9  11 ng/ml 
DUPAN-2  <25 U/ml 
SPan-1  8.1 U/ml 
Glucagon  92 pg/ml 
Gastrin  340 pg/ml 
Insulin  4 mU/ml 
IgG  1,260 mg/dl 
Antinuclear antibody test  negative 
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Fig. 1. a Abdominal ultrasonography showed a 15 mm hypoechoic mass located in the pancreatic body 
without dilatation of the main pancreatic duct (arrow). b Computed tomography revealed a tumor in 
the pancreatic body without any contrast enhancement (arrow). c Magnetic resonance imaging 
demonstrated the mass to be hyperintense on diffusion-weighted image (arrow). d Endoscopic 
retrograde cholangiopancreatography revealed slight dilatation of a branch of the pancreatic duct in 
the pancreatic body without stricture of the main pancreatic duct and the common bile duct (arrow).  
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Fig. 2. a Macroscopically, a well-circumscribed solid and elastic firm tumor about 2 cm in diameter 
with gray-yellow coloration was found. b Histologically, the tumor was not well-circumscribed 
partially and showed extensive fibrosis and infiltration of lymphocytes, plasma cells, and eosinophils 
with lymphoid follicles around the pancreatic duct and pancreatic parenchyma, and obliterative 
venulitis was seen, which are typical features of AIP. H&E staining, × 40. c Immunohistological 
examination demonstrated that the pancreatic duct was surrounded by abundant IgG4-positive 
plasma cells. IgG4 staining, × 40. 
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